Ameriprise’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.9M | Buy |
173,069
+74,788
| +76% | +$4.73M | ﹤0.01% | 1745 |
|
|
2025
Q1 | $5.21M | Buy |
98,281
+44,914
| +84% | +$2.38M | ﹤0.01% | 2277 |
|
|
2024
Q4 | $2.99M | Buy |
53,367
+11,480
| +27% | +$643K | ﹤0.01% | 2683 |
|
|
2024
Q3 | $2.19M | Buy |
41,887
+1,472
| +4% | +$77.1K | ﹤0.01% | 2864 |
|
|
2024
Q2 | $1.66M | Buy |
40,415
+19,435
| +93% | +$798K | ﹤0.01% | 2946 |
|
|
2024
Q1 | $909K | Hold |
20,980
| – | – | ﹤0.01% | 3204 |
|
|
2023
Q4 | $964K | Sell |
20,980
-1,000
| -5% | -$46K | ﹤0.01% | 3202 |
|
|
2023
Q3 | $504K | Buy |
21,980
+3,840
| +21% | +$88K | ﹤0.01% | 3414 |
|
|
2023
Q2 | $299K | Hold |
18,140
| – | – | ﹤0.01% | 3605 |
|
|
2023
Q1 | $324K | Hold |
18,140
| – | – | ﹤0.01% | 3587 |
|
|
2022
Q4 | $528K | Hold |
18,140
| – | – | ﹤0.01% | 3387 |
|
|
2022
Q3 | $445K | Hold |
18,140
| – | – | ﹤0.01% | 3438 |
|
|
2022
Q2 | $75K | Buy |
+18,140
| New | +$75K | ﹤0.01% | 3808 |
|
|
2021
Q1 | – | Sell |
-8,410
| Closed | -$250K | – | 3884 |
|
|
2020
Q4 | $250K | Buy |
+8,410
| New | +$250K | ﹤0.01% | 3567 |
|
|
2020
Q1 | – | Sell |
-12,610
| Closed | -$290K | – | 3721 |
|
|
2019
Q4 | $290K | Sell |
12,610
-25,000
| -66% | -$575K | ﹤0.01% | 3484 |
|
|
2019
Q3 | $812K | Buy |
+37,610
| New | +$812K | ﹤0.01% | 3100 |
|